Company / PP&E per Share
Cytokinetics PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$659.38
FY2025
5-year range
$0.65 / $659.38
FY2021-FY2025
Trend
+101728.5%
vs FY2024
Sector context
#2 of 191
Health Care
What the data says
PP&E per Share changed +101728% YoY in FY2025, a notable deviation from the 9-year average annual change of +11356%.
Based on SEC 10-K filings.
659.38 in FY2025 with a 5-year CAGR of +411.7%. Ranks 2nd among 191 companies in Health Care.
Improved from $0.72 to $659.38 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +785.8%
- 5-Year CAGR
- +411.7%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 191This company $659.38 Sector average $22.34
▼
+2851.2% above sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 101728.5% year-over-year.
- Ranks #2 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $659.38 | +101728.5% |
| FY2024 | $0.65 | -10.7% |
| FY2023 | $0.72 | -23.6% |
| FY2022 | $0.95 | +9.8% |
| FY2021 | $0.86 | +359.8% |
| FY2020 | $0.19 | +145.5% |
| FY2019 | $0.08 | +30.7% |
| FY2018 | $0.06 | -11.4% |
| FY2017 | $0.07 | -26.1% |
| FY2016 | $0.09 | +102.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026